Accueil>>Signaling Pathways>> PROTAC>>TL 13-12

TL 13-12

Catalog No.GC50560

Le TL 13-12 est un dégradeur ALK-PROTAC puissant et sélectif et inhibe l'activité ALK avec une valeur IC50 de 0,69 nM. TL 13-12 provoque également la dégradation de kinases supplémentaires, notamment Aurora A, FER, PTK2 et RPS6KA1 avec des valeurs IC50 de 13,5 nM, 5,74 nM, 18,4 nM et 65 nM, respectivement. TL 13-12 est composé de la conjugaison de TAE684 et du ligand Cereblon de Pomalidomide.

Products are for research use only. Not for human use. We do not sell to patients.

TL 13-12 Chemical Structure

Cas No.: 2229037-04-9

Taille Prix Stock Qté
5 mg
494,00 $US
En stock

Tel:(909) 407-4943 Email: sales@glpbio.com

Avis des clients

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

Selective anaplastic lymphoma kinase (ALK) degrader (DC50 values are 10 and 180 nM in H3122 and Karpas 299 cells, respectively). Comprises the cereblon E3 ligase ligand Pomalidomide , conjugated to an ALK inhibitor. Inhibits proliferation of ALK-positive cancer cell lines. Exhibits higher selectivity for ALK over Aurora A kinase compared with TL 13 -112 (Cat.No. 6745). Maximum degradation is exhibited at 16 h. Negative control TL 13-22 also available.

Powell et al (2018) Chemically induced degradation of anaplastic lymphoma kinase (ALK). J.Med.Chem. 61 4249 PMID:29660984

Avis

Review for TL 13-12

Average Rating: 5 ★★★★★ (Based on Reviews and 34 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for TL 13-12

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.